Related Experiment Video
Updated: Jun 21, 2026

Implementation of a Permeable Membrane Insert-based Infection System to Study the Effects of Secreted Bacterial Toxins on Mammalian Host Cells
Published on: August 19, 2016
Acquisition of factor H by a novel surface protein on group B Streptococcus promotes complement degradation
Ravi Maruvada1, Nemani V Prasadarao, C E Rubens
1Division of Infectious Diseases, Johns Hopkins School of Medicine, 200 N. Wolfe St., Baltimore, MD 21205, USA. rmaruva1@jhmi.edu
Abstract:
Binding of the host complement regulator, factor H (FH), by some pathogenic microbes constitutes an important virulence mechanism, whereby complement is broken down to help microbes survive in the host. Although it has been hypothesized for the past two decades that GBS type III binds FH via sialic acid present on its capsule, neither the binding of FH to GBS has been demonstrated nor the mechanism of interaction identified. We observed that FH bound to both wild-type and capsule or sialic acid-deficient GBS that were used as negative controls. Wild-type and acapsular GBS were incubated with serum or pure FH degraded almost 90% of C3b, suggesting that the GBS-bound FH maintained cofactor activity. In addition, dot-blot analysis showed approximately 5-10% of C5 and C9 formation, as compared to an Escherichia coli control, suggesting breakdown at the C3b level. Protease treatment of the bacteria completely abolished binding of FH. Using overlay assays and mass spectroscopic analysis, we identified the FH receptor as the streptococcal histidine triad (SHT) surface protein. The ability of binding FH to SHT was further confirmed by using recombinant SHT. This report describes the identification of the SHT as an FH-binding protein on the surface of GBS type III, revealing a novel mechanism by which the bacterium acquires FH to evade complement opsonization.
Insights
Group B Streptococcus (GBS) type III evades the host immune system by binding factor H (FH) through its streptococcal histidine triad (SHT) protein. This interaction prevents complement activation, aiding bacterial survival.
Area of Science:
- Microbiology
- Immunology
- Molecular Biology
Background:
- Pathogenic microbes utilize host complement regulators like factor H (FH) as a virulence mechanism to evade immune responses.
- Group B Streptococcus (GBS) type III is hypothesized to bind FH via capsular sialic acid, but this interaction and its mechanism remain unproven.
Purpose of the Study:
- To demonstrate and identify the mechanism of factor H (FH) binding to GBS type III.
- To elucidate how GBS type III utilizes FH to evade complement-mediated opsonization and host defense.
Main Methods:
- Incubation of wild-type and mutant GBS strains with human serum or purified FH.
- Assessment of complement component degradation (C3b, C5, C9) via functional assays.
- Protease treatment of GBS, overlay assays, mass spectrometry, and recombinant protein analysis to identify the FH receptor.
Main Results:
- Factor H (FH) bound to both wild-type and acapsular GBS strains.
- GBS-bound FH retained cofactor activity, leading to significant C3b degradation and reduced downstream complement activation.
- The streptococcal histidine triad (SHT) surface protein was identified as the direct receptor for FH on GBS type III.
Conclusions:
- The streptococcal histidine triad (SHT) protein is a novel factor H (FH)-binding protein on GBS type III.
- GBS type III employs SHT to bind FH, a mechanism that inhibits complement opsonization and promotes bacterial survival within the host.
Related Concept Videos
Complement System
Determinants of Bacterial Pathogenicity and Virulence
Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Regulation of Bacterial Virulence
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Staphylococcal Skin Infections

